BetterLife Pharma Inc. BETR
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -236.03% | -61.95% | 6.92% | 18.09% | -141.87% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 490.02% | 311.03% | -272.35% | 174.04% | 65.73% |
| Change in Net Operating Assets | -411.26% | 237.74% | -85.23% | -15.04% | -3.08% |
| Cash from Operations | -476.39% | 43.34% | -3,481.40% | 93.14% | -1,154.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -3.13% | 0.00% | -77.78% | -- | -- |
| Issuance of Common Stock | 36.47% | 435.89% | -- | -100.00% | 500.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 804.73% | -40.15% | 24,007.69% | -101.02% | 623.86% |
| Foreign Exchange rate Adjustments | -100.00% | -75.00% | 200.00% | -233.33% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,685.47% | 254.55% | 132.35% | -543.48% | -69.74% |